QuiVad

Home / Sweden / Dicot Pharma AB

Dicot Pharma AB

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.46% on October 24, 2025. The shaded band is the year shown above.

August 20, 2024 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

53 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 7, 2026Citadel Securities (Europe) Limited0.55%still open
June 22, 2026Guevoura Fund0.66%still open
June 17, 2026Guevoura Fund1.10%still open
June 16, 2026Guevoura Fund1.02%still open
June 12, 2026Guevoura Fund0.92%still open
June 11, 2026Guevoura Fund0.87%still open
June 9, 2026Guevoura Fund0.66%still open
June 4, 2026Guevoura Fund0.51%still open
June 3, 2026Citadel Securities (Europe) Limited0.51%still open
June 1, 2026Quartys Limited0.79%still open
June 1, 2026Citadel Securities (Europe) Limited0.59%still open
May 11, 2026Brummer Multi-Strategy AB0.62%still open
March 27, 2026Brummer Multi-Strategy AB1.07%still open
March 26, 2026Brummer Multi-Strategy AB0.98%still open
March 18, 2026GSA Capital Partners LLP0.58%still open
March 13, 2026Brummer Multi-Strategy AB0.75%still open
March 12, 2026GSA Capital Partners LLP0.69%still open
March 9, 2026GSA Capital Partners LLP0.78%still open
March 4, 2026GSA Capital Partners LLP0.80%still open
February 24, 2026GSA Capital Partners LLP0.70%still open
February 16, 2026GSA Capital Partners LLP0.61%still open
February 6, 2026GSA Capital Partners LLP0.51%still open
January 30, 2026Brummer Multi-Strategy AB0.54%still open
January 29, 2026Brummer Multi-Strategy AB0.66%still open
January 28, 2026Brummer Multi-Strategy AB0.97%still open
December 30, 2025Brummer Multi-Strategy AB1.32%still open
November 19, 2025Citadel Securities (Europe) Limited0.53%still open
November 14, 2025Citadel Securities (Europe) Limited0.62%still open
November 13, 2025Citadel Securities (Europe) Limited0.57%still open
November 11, 2025Citadel Securities (Europe) Limited0.68%still open
November 10, 2025Citadel Securities (Europe) Limited0.59%still open
November 7, 2025Citadel Securities (Europe) Limited0.75%still open
November 4, 2025Citadel Securities (Europe) Limited0.84%still open
October 30, 2025Citadel Securities (Europe) Limited0.79%still open
October 29, 2025Citadel Securities (Europe) Limited0.56%still open
October 27, 2025Brummer Multi-Strategy AB1.14%still open
October 24, 2025Citadel Securities (Europe) Limited0.79%still open
October 23, 2025Brummer Multi-Strategy AB1.42%still open
September 2, 2025Brummer Multi-Strategy AB1.14%still open
August 27, 2025Brummer Multi-Strategy AB0.90%still open
August 26, 2025Brummer Multi-Strategy AB0.80%still open
September 10, 2024Guevoura Fund1.25%still open
September 6, 2024Guevoura Fund2.61%still open
September 5, 2024Guevoura Fund2.55%still open
September 4, 2024Guevoura Fund2.40%still open
September 3, 2024Guevoura Fund2.37%still open
September 2, 2024Guevoura Fund2.25%still open
August 30, 2024Guevoura Fund2.10%still open
August 27, 2024Guevoura Fund1.81%still open
August 26, 2024Guevoura Fund1.43%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Dicot Pharma AB, source Finansinspektionen, data as at July 7, 2026, https://www.quivad.com/action/dicot-pharma-ab